France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...

Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their ...

Sanofi plans to invest $20 billion in U.S.-based drug R&D and manufacturing over five years, creating jobs and boosting ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.

Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...

France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in ...

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

Sanofi (SNY) commits $20B to U.S. research & manufacturing by 2030, boosting R&D & partnerships amidst industry-wide ...

France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...

Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...